Biodesix Stock Performance
| BDSX Stock | USD 1.69 0.06 3.43% |
Biodesix has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.11, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Biodesix are expected to decrease at a much lower rate. During the bear market, Biodesix is likely to outperform the market. Biodesix right now shows a risk of 2.93%. Please confirm Biodesix maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Biodesix will be following its price patterns.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Biodesix are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Biodesix may actually be approaching a critical reversion point that can send shares even higher in November 2024. ...more
1 | Disposition of 5862 shares by Gary Pestano of Biodesix at 1.9166 subject to Rule 16b-3 | 07/12/2024 |
2 | Disposition of 26368 shares by Watts Charles M of Biodesix subject to Rule 16b-3 | 07/16/2024 |
3 | Medpace Tops Q2 Earnings Estimates | 07/22/2024 |
4 | Disposition of 5435 shares by Patience John of Biodesix subject to Rule 16b-3 | 07/26/2024 |
5 | Biodesix to Present at Canaccord Genuitys 44th Annual Growth Conference | 08/06/2024 |
6 | Biodesix, Inc. Q2 2024 Earnings Call Transcript | 08/08/2024 |
7 | Disposition of 724 shares by Robin Cowie of Biodesix at 1.601 subject to Rule 16b-3 | 08/09/2024 |
8 | Disposition of 251 shares by Robin Cowie of Biodesix at 1.5719 subject to Rule 16b-3 | 08/12/2024 |
9 | Disposition of 434 shares by Gary Pestano of Biodesix at 1.4795 subject to Rule 16b-3 | 09/04/2024 |
10 | Perceptive Advisors LLC Takes 3.33 Million Position in Biodesix, Inc. - MarketBeat | 09/30/2024 |
| Begin Period Cash Flow | 43.2 M |
Biodesix |
Biodesix Relative Risk vs. Return Landscape
If you would invest 159.00 in Biodesix on July 7, 2024 and sell it today you would earn a total of 10.00 from holding Biodesix or generate 6.29% return on investment over 90 days. Biodesix is currently generating 0.1371% in daily expected returns and assumes 2.9341% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than Biodesix, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biodesix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biodesix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biodesix, and traders can use it to determine the average amount a Biodesix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0467
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | BDSX | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.93 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Biodesix is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biodesix by adding it to a well-diversified portfolio.
Biodesix Fundamentals Growth
Biodesix Stock prices reflect investors' perceptions of the future prospects and financial health of Biodesix, and Biodesix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biodesix Stock performance.
| Return On Equity | -3.04 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.73) % | ||||
| Operating Margin | (0.46) % | ||||
| Current Valuation | 266.2 M | ||||
| Shares Outstanding | 145.18 M | ||||
| Price To Book | 6.81 X | ||||
| Price To Sales | 4.03 X | ||||
| Revenue | 49.09 M | ||||
| Gross Profit | 24.06 M | ||||
| EBITDA | (35.79 M) | ||||
| Net Income | (52.15 M) | ||||
| Cash And Equivalents | 15.18 M | ||||
| Cash Per Share | 0.36 X | ||||
| Total Debt | 60.69 M | ||||
| Debt To Equity | 3.20 % | ||||
| Current Ratio | 0.64 X | ||||
| Book Value Per Share | 0.25 X | ||||
| Cash Flow From Operations | (22.87 M) | ||||
| Earnings Per Share | (0.45) X | ||||
| Market Capitalization | 245.35 M | ||||
| Total Asset | 99.1 M | ||||
| Retained Earnings | (419.57 M) | ||||
| Working Capital | 6.27 M | ||||
About Biodesix Performance
Evaluating Biodesix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Biodesix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biodesix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 32.19 | 48.06 | |
| Return On Tangible Assets | (0.68) | (0.72) | |
| Return On Capital Employed | (0.63) | (0.66) | |
| Return On Assets | (0.53) | (0.55) | |
| Return On Equity | (11.39) | (10.82) |
Things to note about Biodesix performance evaluation
Checking the ongoing alerts about Biodesix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biodesix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biodesix may become a speculative penny stock | |
| Biodesix has a very high chance of going through financial distress in the upcoming years | |
| Biodesix currently holds 60.69 M in liabilities with Debt to Equity (D/E) ratio of 3.2, implying the company greatly relies on financing operations through barrowing. Biodesix has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Biodesix's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 49.09 M. Net Loss for the year was (52.15 M) with profit before overhead, payroll, taxes, and interest of 24.06 M. | |
| Biodesix currently holds about 15.18 M in cash with (22.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| Roughly 47.0% of Biodesix shares are held by company insiders | |
| Latest headline from news.google.com: Perceptive Advisors LLC Takes 3.33 Million Position in Biodesix, Inc. - MarketBeat |
- Analyzing Biodesix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biodesix's stock is overvalued or undervalued compared to its peers.
- Examining Biodesix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biodesix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biodesix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biodesix's stock. These opinions can provide insight into Biodesix's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Biodesix Stock Analysis
When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.